Search results for "nuclide [thorium]"

showing 10 items of 75 documents

Generator-Based Radiopharmaceuticals for PET Dosimetry Before, During, and After Endoradiotherapy

2014

Generator-derived radionuclides for PET/CT imaging are promising for optimizing targeted radiotherapy by an individual patient-based approach, applying pre-therapeutic evaluation, dosimetric calculations, and for measuring treatment response after radionuclide therapy. To realize this vision, sophisticated nuclear chemistry and radiopharmaceutical chemistry should coincide with quantitative molecular imaging and dosimetric calculations.

Treatment responsebusiness.industryComputer scienceTargeted RadiotherapyRadionuclide therapyDosimetryCt imagingRadionuclide GeneratorMolecular imagingNuclear medicinebusiness
researchProduct

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS.

2011

Generator-derived radionuclides for PET/CT imaging are promising for optimizing targeted radiotherapy by an individual patient-based approach, applying pre-therapeutic evaluation, as well as dosimetric calculations, and for measuring treatment response after radionuclide therapy.

Treatment responsemedicine.medical_specialtyGenerator (computer programming)business.industryTargeted RadiotherapyInorganic ChemistryHeterocyclic Compounds 1-RingCoordination ComplexesMetalsNeoplasmsPositron-Emission TomographyRadionuclide therapyMedicineHumansMedical physicsMolecular imagingCt imagingRadiopharmaceuticalsbusinessNuclear medicineDalton transactions (Cambridge, England : 2003)
researchProduct

Unusual case of continuous urinary dribbling in a young female due to unknown complex urogenital malformation: magnetic resonance features

2020

Congenital anomalies of kidney and urinary tract (CAKUT) occur in up to 3.2% of infants, and in almost one third of cases they are associated to genital aberrations. DMSA renal scintigraphy is considered the gold standard in CAKUT patients, to assess renal function, depict and locate ectopic kidney and to guide eventual surgical management. Recent cases have shown the noticeable limit of scintigraphy in detecting poorly functional renal moieties and associated genital anomalies; thus leading to a substantial delay in therapy, and, in females, to severe uro-gynecological complications. We herein describe a case of a young girl with unusual urinary dribbling, where DSMA scintigraphy was not d…

Unusual casemedicine.diagnostic_testRadionuclide imagingGenitourinary systembusiness.industryMagnetic resonance imagingGeneral MedicineAnatomyTechnetium Tc 99m dimercaptosuccinic acidMagnetic resonance imagingUrinary dribblingUrogenital abnormalitiesmedicineYoung femalebusinessGazzetta Medica Italiana Archivio per le Scienze Mediche
researchProduct

Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms

2021

Neuroendocrine neoplasms (NENs) are heterogeneous neoplasms which arise from neuroendocrine cells that are distributed widely throughout the body. Although heterogenous, many of them share their ability to overexpress somatostatin receptors (SSTR) on their cell surface. Due to this, SSTR and somatostatin have been a large subject of interest in the discovery of potential biomarkers and treatment options for the disease. The aim of this review is to describe the molecular characteristics of somatostatin and somatostatin receptors and its application in diagnosis and therapy on patients with NENs as well as the use in the near future of somatostatin antagonists.

endocrine systemQH301-705.5CellMedicine (miscellaneous)ReviewGeneral Biochemistry Genetics and Molecular BiologymedicineBiology (General)Tumorspeptide receptor radionuclide therapyReceptors d'hormonesneuroendocrine neoplasmssomatostatin analoguesSomatostatin receptorbusiness.industryTreatment optionsLU-DOTA-TATEmedicine.anatomical_structureSomatostatinPotential biomarkerssomatostatin receptorssomatostatin antagonistsCancer research68Ga PETbusinesshormones hormone substitutes and hormone antagonistsBiomedicines
researchProduct

Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results

2019

Abstract Background Preclinical biodistribution and dosimetric analysis of [177Lu]Lu-DOTAZOL suggest the bisphosphonate zoledronate as a promising new radiopharmaceutical for therapy of bone metastases. We evaluated biodistribution and normal organ absorbed doses resulting from therapeutic doses of [177Lu]Lu-DOTAZOL in patients with metastatic skeletal disease. Method Four patients with metastatic skeletal disease (age range, 64–83 years) secondary to metastatic castration-resistant prostate carcinoma or bronchial carcinoma were treated with a mean dose of 5968 ± 64 MBq (161.3 mCi) of [177Lu]Lu-DOTAZOL. Biodistribution was assessed with serial planar whole body scintigraphy at 20 min and 3,…

lcsh:Medical physics. Medical radiology. Nuclear medicine[177Lu]Lu-DOTAZOLBiodistributionKidneyUrinary bladderbusiness.industrymedicine.medical_treatmentlcsh:R895-920Organ absorbed dosesBone metastasisBisphosphonatemedicine.diseaseProstate carcinomamedicine.anatomical_structureAbsorbed doseRadionuclide therapymedicineRadiology Nuclear Medicine and imagingBone marrowBronchial carcinomabusinessNuclear medicineBone seeking therapeutic radionuclidesOriginal ResearchEJNMMI Research
researchProduct

Klinisch-experimentelle Studie zur szintigraphischen Darstellung maligner Kopf-Hals-Neoplasien mit57Cobalt-Bleomycin

1975

Tumorscanning of malignomas and their metastatic nodules in head and neck is an enrichment of diagnostic possibilities. For the examination such substances can be used, which are tumoraffine and well to mark with a radio-isotope. Therefore we have marked the cytostatic drug Bleomycine with 57Co. Scans were performed with the Anger-Camera 4 to 6 hrs after intravenous injection of 1 mCi 57Co-Bleomycine. 60 patients with different malignomas have been examined, 46 with tumor-localization in head and neck, the others in thoraxabdomen. 34 (85%) of the head and neck malignomas could be demonstrated; 21 (81%) were squamous cell carcinomas, 13 (69%) sarcomas. The possibilities of this method are sh…

medicine.medical_specialtyCobalt RadioisotopesOtorhinolaryngologyOtorhinolaryngologybusiness.industrymedicineHead and neck surgeryRadionuclide imagingGeneral MedicineNeurosurgeryRadiologyHead and neckbusinessArchives of Oto-Rhino-Laryngology
researchProduct

Diagnostic laparoscopy in a Gartner's duct cyst

2008

Gartner's duct cysts associated with renal dysgenesis are rare malformations and represent a diagnostic challenge. We report on one such case in which final diagnosis was achieved by laparoscopy and discuss the possible role of minimally invasive surgery in the management of this condition.

medicine.medical_specialtyGartner’s duct cyst; Urinary incontinence; Laparoscopy; Single kidney; Genital anomalyGartner’s duct cystUrologyUrinary incontinenceDiagnostic laparoscopyKidneyRENAL DYSGENESISmedicineHumansMinimally Invasive Surgical ProceduresRadionuclide imagingSingle kidneyKidney surgeryLaparoscopyChildRadionuclide ImagingUltrasonographymedicine.diagnostic_testbusiness.industryGeneral surgeryGartner's duct cystWolffian Ductsmedicine.diseaseGenital anomalymedicine.anatomical_structurePediatrics Perinatology and Child HealthInvasive surgeryFemaleLaparoscopybusinessDuct (anatomy)
researchProduct

On Taeniasis/Cysticercosis Mimicking Lymphoma on PET/CT Imaging.

2015

medicine.medical_specialtyLymphomabusiness.industryCysticercosisLymphoma diagnosisPet ct imagingCysticercosisGeneral MedicineJejunal Diseasesmedicine.diseaseLymphomaMedicineTaeniasisAnimalsHumansRadiology Nuclear Medicine and imagingRadionuclide imagingFemaleRadiologybusinessRadionuclide ImagingLymphatic DiseasesClinical nuclear medicine
researchProduct

Peptide Receptor Radionuclide Therapy for Neuroendocrine Neoplasms in Germany: a Multi-Institutional Registry Study with Prospective Follow Up on 450…

2013

68 Ga-DOTATOC PET in patients with neuroendocrine tumors (NET). We specifically looked for incremental lesions, defined as lesions only observed on one modality even after extensive retrospective evaluation of the other modality. Methods: Twenty patients with a metastasized NET underwent 111 In-pentetreotide

medicine.medical_specialtyPediatricsgenetic structuresPeptide receptorbusiness.industryRegistry studyHematologyNeuroendocrine tumorsmedicine.diseaseOncologyRadionuclide therapyotorhinolaryngologic diseasesmedicineIn patientRadiologyReceptorbusinesspsychological phenomena and processesAnnals of Oncology
researchProduct

Dual Diagnostic Role of 123I-MIBG Scintigraphy in Inverted Takotsubo Cardiomyopathy : Reply [Letter]

2016

International audience

medicine.medical_specialty[SDV]Life Sciences [q-bio]123i mibg scintigraphyCardiomyopathy[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine3-Iodobenzylguanidine030218 nuclear medicine & medical imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciences0302 clinical medicineTakotsubo CardiomyopathyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingRadionuclide imaging[ SDV.IB ] Life Sciences [q-bio]/BioengineeringRadionuclide ImagingComputingMilieux_MISCELLANEOUS[ SDV ] Life Sciences [q-bio]business.industryGeneral Medicinemedicine.disease3. Good health3-Iodobenzylguanidine030220 oncology & carcinogenesisCardiology[SDV.IB]Life Sciences [q-bio]/BioengineeringNuclear medicinebusiness
researchProduct